All around the world, acutely ill and injured people of all ages seek care every day. They will
call neighbors, the police, or universal emergency numbers for help. They will be assisted by …

Cardiovascular disease (CVD) is the leading cause of global deaths, with the majority
occurring in low-and middle-income countries. The primary and secondary prevention of …

Background A significant proportion of cardiovascular disease (CVD) morbidity and mortality
could be prevented via the population-based and cost-effective interventions. A fixed-dose …

Background New pharmacological therapies for the treatment of cardiovascular disease
(CVD) have emerged in recent years. The high rates of CVD and the need for long-term …

Background: Cardiovascular (CV) diseases remain a leading and costly cause of death
globally. Patients with previous CV events are at high risk of recurrence. Secondary …

Introduction: The emphasis on clinical trials to inform evidence-based medicine remains
paramount within the cardiovascular community. Although such high-quality evidence is …

Abstract Background The Use of Multidrug Pill In Reducing cardiovascular Events (UMPIRE)
trial, showed that access to a cardiovascular polypill (aspirin, statin and two blood pressure …

Background—Whether to cover cardiovascular disease costs is an increasingly pressing
question for low-and middle-income countries. We sought to identify the impact of expanding …

Hyperlipidemia is a risk factor for cardiovascular disease–the leading cause of death
globally. Increased understanding of the cost-effectiveness of hyperlipidemia treatment in …

Background This study aims to assess the cost-effectiveness of optimized guideline
adherence in patients with a history of coronary heart disease. Methods An individual-based …